32.3 C
Vientiane
Saturday, August 2, 2025
spot_img
Home Blog Page 114

Bird and Segway Partner to Launch Next-Gen Shared Micromobility Fleet Across North America

 Industry Leaders Unite to Deliver Smarter, Safer, and More Sustainable Urban Rides

BEIJING, July 22, 2025 /PRNewswire/ — Bird, a pioneer in shared micromobility, and Segway, a global leader in electric vehicle innovation, announced a strategic alliance to roll out advanced new electric scooters and e-bikes across key North American markets. This next-generation fleet combines Segway’s engineering excellence with Bird’s operational expertise to set new standards for performance, safety, and sustainability in urban transportation.

3 co-developed vehicles
3 co-developed vehicles

The partnership introduces three co-developed models—the Bird Dash, Bird Explorer, and Bird Journey—designed to meet diverse rider needs, from daily commuting to recreational trips. All three models feature improved vehicle durability, cutting-edge safety systems, and a lower environmental footprint, with deployments beginning this summer across North America.

“This collaboration brings together the best of what Bird and Segway offer: world-class technology, rider-first design, and innovation to deliver more sustainable urban mobility,” said Stewart Lyons, Co-CEO of Bird. “Together, we’re shaping the future of micromobility by expanding access to safe, reliable, and efficient transportation in cities and communities around the world.”

Optimized for Efficiency and Performance

The new vehicles are equipped with IPX7-rated water resistance, reinforced structures, and low-maintenance components that increase reliability and reduce operational costs. The Bird Journey e-bike offers a range of up to 90 kilometers on a single charge—supporting longer commutes with fewer battery swaps. Optimized energy usage lowers standby power and delivers greater efficiency across fleets. These durability and efficiency improvements collectively reduce total cost of ownership (TCO) , delivering superior long-term value.

Rider feedback for this initial launch has been exceptional, resulting in a 40% increase in ridership of these new vehicles. Riders particularly like the smooth ride, sleek look and feel and features like the new charging block for your mobile device. Coming from Bird Team

Commitment to Safety and Compliance

All three models feature enhanced braking systems (dual drum + electric), bright LED lighting with turn indicators, and onboard sensors to detect sidewalks and pedestrians—triggering alerts and automatic speed adjustments to help prevent collisions. Each model exceeds industry safety benchmarks, including UL2272 and UL2849 certifications.

“Segway has always pushed the boundaries of intelligent mobility,” said Alan Zhao, General Manager of the Sharing Business Division. “With Bird, we’re delivering a smarter and safer riding experience, purpose-built for today’s cities and tomorrow’s expectations.”

Designed for Sustainability

Sustainability is embedded into every layer of the new fleet—from recycled materials and modular parts to closed-loop packaging and longer-life batteries. These upgrades support Bird and Segway’s shared goal of building a more circular economy and advancing climate-friendly mobility at scale.

Together, Bird and Segway are redefining what’s possible in shared mobility—empowering cities and riders alike with smarter, safer, and more sustainable ways to move. This launch marks just the beginning of their continued collaboration to build the future of micromobility.

Precision Era to Redefine Treatment, Drive $450B Economic Investment and Change Lives Across Asia Pacific

SINGAPORE, July 22, 2025 /PRNewswire/ — The Precision Era of medicine is arriving in Asia Pacific, driven by the arrival of a critical mass of innovative therapies that will redefine treatment, attract investment and improve lives, a new expert-driven report finds.

Released today, ‘On the Cusp of a Cure’ White Paper examines Asia Pacific’s readiness for the Precision Era – the current, transformative period where generically prescribed and regularly administered treatments are increasingly giving way to potentially curative therapies tailored to individuals and their disease. Treatments called precision therapies

Across the four markets over the next 10 years, the new research by L.E.K. Consulting and an advisory committee of 16 Asia Pacific experts using a proprietary ‘whole system benefits modelling’ approach found that the Precision Era has the potential to:

  • Drive direct economic investment of approximately USD 450 billion.[i]
  • Create almost 1.2 million highly skilled jobs[i] in R&D, advanced manufacturing and biotechnology.
  • Drive USD1.615 trillion in broader[i], indirect economic benefit via a multiplier effect across adjacent industries.
  • Save healthcare systems across the four markets USD 39 billion[i], alleviating intense pressure on resources.
  • Increase workforce participation for 24 million patients and caregivers by improving their ability to return or stay in work.[i]

“The Precision Era is being driven by the arrival of a critical mass of some 4,000 innovative cell and gene therapies that will redefine treatment, attract investment and improve lives. Never before have we had such a clear view of the huge potential that this new era holds for Asia-Pacific. Healthcare systems stand to save billions, and patients could potentially live healthier for longer. The broader economic impact of this new era medicine is equivalent to South Korea’s annual GDP, and the potential for new jobs greater than the entire population of Adelaide,” said Stephanie Newey, Managing Partner, Head of L.E.K. Consulting Australia.

Precision therapies put us on the cusp of a cure

The ‘On the Cusp of a Cure’ research assessed data from more than 1,000 clinical trials across four novel technologies – gene therapies, targeted antibody therapies, drug-device combination therapies, and diagnostic technologies. These precision therapies are considered part of the Precision Era because they provide enhanced health benefits through a more tailored approach, represent a paradigm shift to how care has been provided previously and are the focus of significant research and investment.

Critically, some experts suggest we may be on the cusp of a cure for diseases that have previously been considered incurable and represent Asia-Pacific’s most pressing health challenges, such as many cancers and genetic disorders.  

Asia disproportionately carries the largest cancer and rare disease burden in the world. It shoulders nearly half of all global cancer incidence[ii] and is home to 258 million people who are living with rare diseases[iii]. Worse still, these numbers are only expected to grow, fuelling calls for sustainable, scalable and effective solutions. Precision therapies are stepping forward to meet this critical need and represent a new standard of care for many of Asia-Pacific’s health challenges,” said Professor Baorong Yu, from the University of International Business and Economics in China.

One of the most groundbreaking examples of these treatments is chimeric antigen receptor T-cell (CAR-T) therapy that modifies the body’s own T cells (a type of white blood cell) to target and destroy cancer cells[iv]. It is commonly used in the treatment of blood cancers, which has a 50% survival rate for over a third of patients. Currently, these patients are mostly treated through chemotherapy and radiotherapy, but many do not respond or will relapse.

“With increased access to innovative treatments such as CAR-T therapy, particularly earlier in treatment regimes, patients could live longer with a better quality of life,” said Naomi Sakurai, Advisory Committee member and Founder and CEO, Cancer Solutions. “Rather than going through multiple rounds of chemo, they would have a therapy tailored specifically to their condition. These precision treatments are now offering hope by potentially curing once-incurable diseases and giving people the priceless gift of more time with their loved ones.”

What’s holding back the adoption of precision therapies?

The Precision Era brings fundamental change to the way disease is approached and how patients are treated, and requires an equivalent rethink from regulators and policymakers.  

While each market has its own, unique policy environment, ‘On the Cusp of a Cure’ series found that Australia, China, Japan, and South Korea all exhibit similar barriers to precision therapy adoption. Rules remain unclear for evaluating the reimbursement of new precision therapies, there is limited awareness among patients and doctors about these treatments, and better healthcare infrastructure is needed to support access.

The ‘On the Cusp of a Cure’ research presents a number of regional solutions to unlock the potential benefits of precision therapies:

Establish streamlined regulatory and reimbursement pathways specifically tailored for these treatments

Increase education for providers, patients, and the community to enhance understanding of the Precision Era

Enhance public-private collaboration to foster innovation and equitable access to precision therapies.

Improve access and affordability through pricing strategies, reimbursement frameworks, and insurance initiatives for treatments and diagnostics alike.

Through clinical guidelines and knowledge sharing, empower HCPs to make informed decisions about precision therapies, and assist patients in complex treatment paths.

By backing local industry investments in therapies and diagnostics, and nurturing expertise, joint efforts can drive sustainable progress towards transformative innovations.

“With this new era of precision therapies, we stand at the threshold of transforming healthcare across Asia-Pacific,” said Sakurai. “But for the full potential of these medicines to materialise, regulatory systems as well as knowledge and infrastructure must keep up. The goal of precision therapies is to ensure the right patient, right timing, right treatment and right dose. We all have a role to play, including policymakers, healthcare professionals, and healthcare industry leaders, to remove barriers for patients to these potentially life-changing therapies.”

“On the Cusp of a Cure White Paper Asia Pacific Series is made up of four local market white papers evaluating barriers to precision therapy adoption, providing recommendations for improvement, and assessing the value of widespread adoption in Australia, China, Japan, and Korea.

Notes to Editor: On the Cusp of a Cure White Paper Series and Advisory Committee Members

The On the Cusp of a Cure whitepaper series was supported by an advisory committee of 16 pre-eminent regional experts in precision medicine, economic and health policy, and patient experience across Australia, China, Japan and Korea. It was also sponsored by Johnson & Johnson.

Australia

China

South Korea

Japan

David Thomas, Chief Scientific Officer, Omico

Jaala Pulford, Chair of the Board, MTPConnect

Christine Cockburn, CEO, Rare Cancers Australia

 

Baorong Yu, Professor and market access key opinion leader, University of International Business and Economics

Andy Mok, Head of China, Guardant Health

Kevin Huang, Founder and president, China Organization for Rare  Disorders (CORD)

Caicun Zhou, Professor and lung cancer key opinion leader, School of Medicine, Tongji University 

Paul Lee, Former GM, Gilead Sciences Korea

Jin-Ah Kim, Advocate for rare diseases, Seoul National University Hospital, Department of Genomic Medicine, Rare Disease Centre

Prof Jeonghoon Ahn, Professor of Health Convergence, Ewha University

 

Teruyuki Katori, Representative Director, Special Appointed Professor, Future Institute Wolong, General Incorporated Association Graduate School of Social Sciences, University of Hyogo

Daisuke Sato, Professor. Fujita Health university

Manabu Muto, Professor, Kyoto University Graduate School of Medicine

Masahiro Miyake, Professor, Kyoto University Hospital

Naomi Sakurai, Founder and CEO, Cancer Solutions

Keisuke Shimizu, Leader, Lung cancer HER2 “HER HER”

About L.E.K. Consulting

We’re L.E.K. Consulting, a global strategy consultancy working with business leaders to seize competitive advantage and amplify growth. Our insights are catalysts that reshape the trajectory of our clients’ businesses, uncovering opportunities and empowering them to master their moments of truth. Since 1983, our worldwide practice — spanning the Americas, Europe, Middle East and Asia-Pacific — has guided leaders across all industries from global corporations to emerging entrepreneurial businesses and private equity investors. Looking for more? Visit www.lek.com

[i] L.E.K Consulting. On the Cusp of a Cure 2025.

[ii] Huang J, Ngai CH, Deng Y, Tin MS, Lok V, Zhang L, Yuan J, Xu W, Zheng ZJ, Wong MCS. Cancer Incidence and Mortality in Asian Countries: A Trend Analysis. Cancer Control. 2022 Jan-Dec;29:10732748221095955. doi: 10.1177/10732748221095955. PMID: 35770775; PMCID: PMC9252010.

[iii] IQVIA. Rare Diseases in APAC: The Unmet Potential. Available from https://www.iqvia.com/-/media/iqvia/pdfs/asia-pacific/white-papers/rare-disease-landscape-in-the-apac-region_part-1_web-copy-4.pdf Accessed April 2025.

[iv] American Cancer Society. CAR T-cell therapy and Its Side-effects. Available from https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell1.html#:~:text=Chimeric%20antigen%20receptor%20(CAR)%20T,treatments%20are%20no%20longer%20working

 

Cloud4C Unveils Advanced AI-powered Cybersecurity Innovations in Cambodia, Amidst Rising Cyberattacks in the Country

PHNOM PENH, Cambodia, July 22, 2025 /PRNewswire/ — Cloud4C, the world’s leading application-focused multi-cloud MSP and a trusted cybersecurity transformation partner, announces a suite of cutting-edge, AI-powered cybersecurity offerings in Cambodia. This aims to safeguard organizations from rising digital volatility in the state via coordinated cyberthreats.

Cloud4C is particularly attentive to the recent online release by the country’s Ministry of Post and Telecommunications (MPTC) warning public organizations, private firms, and the general masses of a surge in “Distributed Denial of Service (DDoS) attacks, unauthorized access to website control systems, and account breaches affecting both users and system administrators.”

The ministry suggests increased cyber vigilance and urgent implementation of deeper cyber defense frameworks such as 2FA-MFA, anti-phishing mechanisms, and DDoS protection systems to thwart the impending waves of cyber malice.

In response, Cloud4C has unveiled its advanced AI-powered MXDR suite supported by world-class managed SOC services. The platform plus expert supervision renders proactive resilience against all forms of cyberthreats across IT/cloud cores, networks, private infrastructure, business platforms, applications, endpoints, and user footprints. Combining in-depth telemetry orchestration with unique intelligence, the platform predicts vulnerabilities and patches gaps ideally before breaches occur. Should an unfortunate incident still happen, automated workflows immediately trigger alerts for urgent threat containment and response mediation. This adds to Cloud4C’s existing sovereign, secure industry cloud offerings in Cambodia, rendering security-first operations for institutions of any scale.

“We’re committed to protecting Cambodia’s digital sovereignty and the cyber-posture of all its institutions. Cloud4C is mission-adept in securing complex operational environments in a platform-agnostic manner, rendering firms the customizability they need to act fast in this red-alert scenario. We’re engaging with Cambodian enterprises in augmenting their current postures and architecting AI-powered cybersecurity strategies for a fully risk-proof present and future,” mentioned Chaitanya Reddy, Country Head – CLMV Market, Cloud4C.

About Cloud4C 

Cloud4C is a global leader in Automation-driven Multi-cloud Managed Services and Managed Security Services, helping 4,000+ enterprises across 29 countries including 50+ Global Fortune 1000 companies scale with confidence. Cloud4C offers end-to-end sovereign intelligent cloud transformations, digital solutions for enterprises across all sizes and key industries, rendering innovative business reinventions with uncompromised security and localized compliance. From root infrastructure (public/private/hybrid/multi-cloud) to virtualizations, autonomous operations, to application modernization, intelligent cybersecurity-DR, and next-gen technology integrations, we empower enterprises to thrive globally in the modern era. 

For enquiries, email to: globalsales@cloud4c.com

OMRON Healthcare Singapore partners with bolttech and QBE to launch innovative embedded health solution

The comprehensive subscription programme offers OMRON customers in Singapore access to personalised health protection and insights

SINGAPORE, July 22, 2025 /PRNewswire/ — Global insurtech bolttech and OMRON Healthcare Singapore, a global leader in innovative medical equipment for health monitoring and therapy, today announced the launch of their Premium Care subscription plan in Singapore. This three-in-one premium subscription programme offers registered OMRON connect members personalised health insights, protection and exclusive services tailored to OMRON device owners. Underwritten by QBE, a global insurer present in Singapore for over a century, the plan is now available for all owners of OMRON blood pressure monitors with wireless connectivity.

 

Unveiling Premium Care by OMRON Healthcare Singapore, launched in partnership with global insurtech bolttech, and insurer QBE. Supercharge your health protection with AI-powered Blood Pressure status insights, priority service and up to S$10,000 Protective coverage. A plan for the health-conscious, making preventive heart health easier and more rewarding.

The Premium Care plan offers subscribers three key features:

1.  Monthly blood pressure status reports: Customers can receive monthly AI-powered blood pressure status reports. The reports provide personalised summaries of their latest blood pressure status and practical, data-driven recommendations for self-management, enabling customers to make more informed and proactive health decisions together with their healthcare providers.

2.  Step-up insurance coverage: Customers can get automatic access to health protection with coverage of up to SG$10,000 for heart attacks and strokes, alongside worldwide accidental death coverage. Members start with a base coverage of SG$2,000 which goes up to SG$10,000 by using the OMRON Connect app to regularly monitor their blood pressure. Coverage increases with consistent usage and maintaining healthy readings, promoting proactive health management.

3.  Comprehensive device protection: Customers can enjoy upgraded warranty coverage which includes device repairs arising from accidental damage and battery leakage. With premium doorstep pick-up and drop-off delivery service, customers can also benefit from having their devices serviced by the OMRON Service Centre, secure handling, and end-to-end logistics included in the plan – all without the need to leave their homes.

Masanori Matsubara, Managing Director – OMRON Healthcare Singapore, said, “At OMRON, we’re committed to realising the vision of “Going for Zero” – a society with Zero cardiovascular deaths. Partnering with bolttech and QBE is a transformative step forward. We are able to deliver innovative embedded protection, and meet our customers where they are – in their homes, on their devices, and in their daily lives. This collaboration brings together our health expertise with bolttech’s digital capabilities and QBE’s insurance solutions to offer a seamless, personalised experience that truly empowers individuals to take control of their health with confidence.”

Koh Yen Yen, General Manager – Singapore, bolttech, said, “With the Premium Care plan, we’re redefining what connected health can look like. By embedding intelligent protection directly into the customer journey, we’re not just offering insurance, we’re empowering people to take charge of their health with real-time insights, seamless services, and meaningful coverage. We’re excited to partner with OMRON and QBE, to provide customers with potentially lifechanging health monitoring technology. This innovative, all-in-one solution will empower people to manage their health proactively, with greater confidence and ease.”

Ronak Shah, CEO of QBE Singapore, said, “By underwriting the Premium Care plan, QBE is proud to play a part in a forward-thinking partnership with both OMRON and bolttech that combines technology, health insights, and meaningful coverage to deliver real value to customers. The plan’s step-up insurance coverage aligns with our own thinking around innovative insurance solutions. It rewards subscribers that consistently use the technology to monitor  their cardiovascular health, on the basis that  this will help them lead healthier lifestyles, ultimately prolonging lives, reducing medical expenditure overall.”

Introducing Premium Care by OMRON Healthcare Singapore – a first-of-its-kind subscription in Singapore, launched in partnership with global insurtech bolttech and insurer QBE. Designed for OMRON wireless Blood Pressure monitor users, it delivers AI-driven Blood Pressure insights, health protection, and priority services – all from just 30 cents a day. Take control of your health with smarter, proactive care.
Introducing Premium Care by OMRON Healthcare Singapore – a first-of-its-kind subscription in Singapore, launched in partnership with global insurtech bolttech and insurer QBE. Designed for OMRON wireless Blood Pressure monitor users, it delivers AI-driven Blood Pressure insights, health protection, and priority services – all from just 30 cents a day. Take control of your health with smarter, proactive care.

As part of the programme’s launch promotion, all new subscribers to the OMRON Premium Care plan will be entitled to a free one-month subscription.

For more information on the Premium Care service, please visit:

https://member-sg.omron.asia/PremiumCare

About OMRON

OMRON Healthcare is committed to enhancing health and empowering people worldwide to live optimally. OMRON is a global leader in providing clinically validated, innovative medical devices for home health monitoring and care.

Aiming to achieve its vision of “Going for Zero, Preventive Care for the Health of Society,” OMRON develops a wide range of products and services for cardiovascular management, remote patient monitoring, respiratory care, and pain therapy. These solutions are designed to assist healthcare professionals and patients in reducing the risk of cerebro-cardiovascular diseases, preventing the worsening of respiratory conditions, and alleviating restrictions caused by chronic pain.

With more than 350 million units sold globally*, OMRON is the most recommended blood pressure monitor brand by healthcare professionals worldwide**. Since its inception, OMRON Healthcare has been striving to improve the quality of life and contribute to healthier living through innovations that support the prevention, treatment, and management of medical conditions. Currently, OMRON products and services are available in more than 130 countries***.

For more information, please visit https://www.omronhealthcare-ap.com/sg.

Cumulative sales of home-use digital blood pressure monitors worldwide (as of May 2023).

**1 Frost & Sullivan Survey, medical professional perception survey on blood pressure monitors (November 25, 2019, and U.S. News Staff Report 2020, accessed on June 9, 2020).

**2 Kantar Health Survey among cardiologists (2019).

*** Number of countries where OMRON products and/or services are available (as of March 2023). 

About bolttech

bolttech is a global insurtech with a mission to build the world’s leading, technology-enabled ecosystem for protection and insurance. bolttech serves customers in 37 markets across Asia, Europe, North America, and Africa.

With a full suite of digital and data-driven capabilities, bolttech powers connections between insurers, distributors, and customers to make it easier and more efficient to buy and sell insurance and protection products.

For more information, please visit www.bolttech.io.

About QBE Singapore

Present in Singapore for more than a century, QBE Insurance (Singapore) Pte Ltd, a general insurance and reinsurance company, is the Republic’s oldest registered Australian company.

Established in 1891, QBE Singapore is a trusted provider of specialist expertise and professional insurance services. Our insurance specialists develop leading-edge products that are client-focused, delivering cover tailored to deal with everything from complex risks to more simple and straightforward insurance needs.

QBE Insurance (Singapore) Pte Ltd is part of the QBE Insurance Group which is listed on the Australian Securities Exchange and headquartered in Sydney.

For more information, visit www.qbe.com/sg   

AUPU’s ARCHIDEX 2025 Triumph: Redefining Home Comfort in SE Asia


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 22 July 2025 – ARCHIDEX 2025 wasn’t just an exhibition—it was a statement. AUPU, a global leader in home comfort tech, solidified its position as an innovator at the 24th edition of Kuala Lumpur’s premier architecture and design show, with a showcase that underscored its strategic focus on solving regional lifestyle pain points.

AUPU’s ARCHIDEX 2025 Triumph: Redefining Home Comfort in SE Asia

The brand’s success hinges on three key pillars: functionality, wellness, and localization. Take the Beauty Fan & Heater: beyond heating and ventilation, its integration of infrared therapy taps into rising consumer demand for “wellness-at-home” solutions, blending utility with self-care—a trend resonating strongly across urban Southeast Asia.

In humid markets like Malaysia, the Cloth Dryer addressed a critical gap. Its ceiling-mounted design, UV sterilization, and rapid drying capabilities directly solve moisture-related challenges, aligning with local needs for space efficiency and hygiene. Attendees—from architects to homeowners—praised its ability to merge practicality with regional relevance, a hallmark of AUPU’s market positioning.

The Central Kitchen Air Conditioner further demonstrated this approach. Traditional ACs struggle in kitchens due to grease and heat, but AUPU’s specialized design—with targeted airflow and durable components—reimagines cooking spaces as comfortable, usable areas. This innovation reflects a deep understanding of how families live: kitchens aren’t just for cooking; they’re social hubs.

Technologically, AUPU’s edge lies in seamless integration. AI-powered temperature regulation, motion-sensing ventilation, and smart energy management aren’t add-ons—they’re core to the user experience. These features don’t just boost performance; they reduce operational hassle, a key differentiator in a crowded market.

Looking ahead, AUPU’s upcoming Kuala Lumpur flagship store (S-01-05, D’Rapport Ampang) signals more than expansion—it’s a commitment to accessibility. By moving from exhibition halls to a physical retail hub, the brand bridges the gap between innovation and adoption, making premium comfort tech tangible for Malaysian households.

In short, ARCHIDEX 2025 wasn’t just a win for AUPU—it was proof that home comfort, when rooted in local needs and smart tech, can redefine how we live.

Hashtag: #AUPU

The issuer is solely responsible for the content of this announcement.

Agoda launches first-ever brand campaign in Singapore with AI-powered commercials

SINGAPORE, July 22, 2025 /PRNewswire/ — Digital travel platform Agoda launched its first-ever brand campaign in Singapore, centred around an AI-powered commercials that spotlights the company’s flights offering in Singaporean fashion.

Building on the success of Agoda’s previous AI-led activations in India, this latest campaign leverages cutting-edge AI video generation platforms like Google Veo, Runway, and Kling AI to produce a film that spotlights the value of booking flights on Agoda’s platform, but with a distinctly Singaporean touch. Aside from the in-house ideation and voice-over recording, all the visual elements of the creative were created using the latest generative AI technology.

Singapore, Agoda’s home base and a global aviation hub, couldn’t be a better place to kick off our flights-focused campaign,” said Matteo Frigerio, Chief Marketing Officer at Agoda. “Agoda has long been synonymous with amazing accommodation deals, and now, with our first-ever brand campaign in Singapore, we’re turning the spotlight on our incredible airfare offers. Powered by cutting-edge generative AI, we’re showing travellers that Agoda is the ultimate destination for innovation and unbeatable value, all starting right here in Singapore!”

The AI-powered commercial videos are live now on digital channels YouTube and Meta. The campaign is supplemented by a multi-channel social media strategy that spans YouTube, Meta, and TikTok. The campaign highlights Agoda’s great value flight deals, with flights from Singapore starting at just SGD 39.

The commercials are now live and can be viewed here and here.

Singapore Airlines Enhances Customer Experience Analytics with Qualtrics

SINGAPORE, July 22, 2025 /PRNewswire/ — Qualtrics, the leader and creator of the experience management category, today announced that Singapore Airlines (SIA) is using its solutions to enhance its collection, processing, and analysis of customer responses, enabling deeper insights across multiple feedback channels.

The three-year agreement supports SIA’s efforts to better understand customer concerns and preferences through research, data analytics, and artificial intelligence (AI). This approach allows SIA to gather comprehensive customer experience data across multiple channels, helping identify evolving preferences and address concerns across various touchpoints.

“Singapore Airlines uses Qualtrics’ text analytics to process and analyse customer feedback from multiple channels. By integrating advanced analytics with our customer experience strategies, we can better understand our customers’ evolving expectations, address their needs more effectively, and enhance their end-to-end journey with Singapore Airlines,” said Melvin Ng, Vice President of Customer Experience at Singapore Airlines.

SIA is also exploring how to leverage Qualtrics’ GenAI capabilities to enhance analysis of open-ended customer feedback. This would help the airline extract more meaningful insights from written comments and suggestions to improve the customer travel journey.

“Companies that deliver great experiences build deeper relationships with their customers, and today’s market leaders are proven to have made this a greater priority over the last three years,” said Brad Anderson, President at Qualtrics. “As consumer feedback habits evolve, thousands of leading organisations across the world, including Singapore Airlines, are using Qualtrics to understand and improve their customer experience with omnichannel insights captured across the customer journey. These rich insights provide companies with intelligence and capabilities they need to win now and in the coming era of agentic AI,” Anderson concluded.

About Singapore Airlines
The Singapore Airlines (SIA) Group’s history dates to 1947 with the maiden flight of Malayan Airways. The airline was later renamed Malaysian Airways and then Malaysia-Singapore Airlines (MSA). In 1972, MSA split into Singapore Airlines and Malaysian Airline System. Initially operating a modest fleet of 10 aircraft to 22 destinations in 18 countries, SIA has since grown to be a world-class international airline group that is committed to the constant enhancement of the three main pillars of its brand promise: Service Excellence, Product Leadership, and Network Connectivity. Singapore Airlines is the world’s most awarded airline. For more information, please visit http://www.singaporeair.com 

About Qualtrics
Qualtrics is trusted by thousands of the world’s best organizations to power exceptional customer and employee experiences that build deep human connections, increase customer loyalty, boost employee engagement, and drive business success. Our advanced AI and specialized Experience Agents allow businesses and governments to proactively interact with customers and employees in personalized ways across every channel and touchpoint, respond in-the-moment to fix or improve experiences, and stay across the latest market trends and opportunities.

Contact: Tahra De Souza Lane, press@qualtrics.com

Bayes Market Launches New Social Prediction Platform, Transforming Human Insight into Tradable Asset

HONG KONG, July 22, 2025 /PRNewswire/ — Bayes Labs team announces the official launch of Bayes Market, a next‑generation global prediction market based in Asia. Bayes Market converts future events into structured financial contracts, offering professionals and mass population a groundbreaking tool to hedge and trade.

In an era marked by AI, deglobalization, and geopolitical uncertainty, Bayes Market opens a fresh arena beyond traditional asset—a platform where insights about the future can be priced, traded, and monetized.

Trading on Probability, Filling Gaps in Traditional Finance

Bayes Market operates as a prediction market not relying on a single underlying asset, but around information. Users of prediction market trade on probabilities of events from geopolitics, climate to K-pop group comebacks base on their own believes.

Each contract’s price reflects the market’s collective assessment of an event’s probability. Instead of forcing investors to hedge indirectly via ETFs or options, Bayes Market offers a direct hedge on the event itself, addressing a critical blind spot. Users can turn tomorrow’s uncertainty into today’s actionable trade, in a granular way.

Asian Dynamic Meets AMM

Bayes Market employs an Automated Market Maker (AMM) to deliver low‑slippage, high‑transparency trading experience. At the same time, the platform focuses on long‑tail events, making prediction approachable, diverse, and culturally relevant especially in Asia.

The team believes that everyone should be able to trade and create events that of their own interest. Bayes Market covers entertainment, pop culture, and social issues beyond macroeconomics and politics, embedding prediction in our daily lives. This unlocks the mass market adoption beyond crypto users.

Decentralized Market Creation

Bayes Market will soon let users initiate their own prediction events, whether it is a dating reality show or inflation. This challenges the existing paradigm where centralized institutions define tradable markets, turning prediction markets into a grassroots catalyst of shared reality. Stay tuned for Bayes Market’s next version update.

An Ecosystem for a ‘Cognition‑as‑Value’ Market Economy

Bayes Market is now officially launched, supporting Bayes Points and USDC, with Points incentive programs. The platform invites data providers, content platforms, communities, and Web3 innovators to co‑create an ecosystem where cognition itself becomes a new type of value.

About Bayes Market

Bayes Market is founded by a cross‑disciplinary team specializing in market design, digital media, algorithmic modeling, and decentralized finance, dedicated to building a fairer and smarter information market.

Official Website: https://bayes.market

Contact: Chengcai Ji, info@bayeslabs.tech